A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(13 sites)
United States
Stanford University Medical Center, Palo Alto, California Neuro Medicine Hospital / UF Health, Gainesville, Florida Kennedy Krieger Institute, Baltimore, Maryland Massachusetts General Hospital, Boston, Massachusetts University of Minnesota, Minneota, Minnesota Health University of Utah, Salt Lake City, Utah Argentina
Hospital Austral, Buenos Aires Brazil
Federal University of Sao Paulo, São Paulo France
ICM La Pitie Salpetriere, Paris Germany
Klinik und Poliklinik für Neurologie-Leipzig, Leipzig India
Sir Ganga Ram Hospital, New Delhi Spain
Hospital 12 de Octubre, Madrid United Kingdom
National Hospital for Neurology and Neurosurgery, London Last updated November 2025